Roche lung cancer drug helps patients live nearly six months longer than competitors, study finds

A Roche drug billed as a potential blockbuster helped patients with a form of lung cancer that had spread live almost six months longer than two competitive medicines, according to new findings.

Detected & updated continuously · Source: Nebula